Regional vulnerability of brain white matter in vanishing white matter

[1]  M. A. van de Wiel,et al.  Radiological correlates of episodes of acute decline in the leukodystrophy vanishing white matter , 2022, Neuroradiology.

[2]  Lydia W. S. Finley,et al.  Regulation and function of the mammalian tricarboxylic acid cycle , 2022, The Journal of biological chemistry.

[3]  Jeremy J. Carver,et al.  The ProteomeXchange consortium at 10 years: 2023 update , 2022, Nucleic Acids Res..

[4]  S. van der Sluis,et al.  Cortical Pathology in Vanishing White Matter , 2022, Cells.

[5]  M. Kanehisa,et al.  KEGG for taxonomy-based analysis of pathways and genomes , 2022, Nucleic Acids Res..

[6]  N. Mitro,et al.  Rewiring of Glucose and Lipid Metabolism Induced by G Protein-Coupled Receptor 17 Silencing Enables the Transition of Oligodendrocyte Progenitors to Myelinating Cells , 2022, Cells.

[7]  P. Thomas,et al.  PANTHER: Making genome‐scale phylogenetics accessible to all , 2021, Protein science : a publication of the Protein Society.

[8]  D. Reich,et al.  A lymphocyte–microglia–astrocyte axis in chronic active multiple sclerosis , 2021, Nature.

[9]  O. Elroy-Stein,et al.  The Energy Status of Astrocytes Is the Achilles’ Heel of eIF2B-Leukodystrophy , 2021, Cells.

[10]  M. S. van der Knaap,et al.  Isocaloric low protein diet in a mouse model for vanishing white matter does not impact ISR deregulation in brain, but reveals ISR deregulation in liver , 2020, Nutritional neuroscience.

[11]  Minoru Kanehisa,et al.  Toward understanding the origin and evolution of cellular organisms , 2019, Protein science : a publication of the Protein Society.

[12]  S. van der Sluis,et al.  Vanishing white matter: deregulated integrated stress response as therapy target , 2019, Annals of clinical and translational neurology.

[13]  O. Elroy-Stein,et al.  eIF2B Mutations Cause Mitochondrial Malfunction in Oligodendrocytes , 2019, NeuroMolecular Medicine.

[14]  J. Vilo,et al.  g:Profiler: a web server for functional enrichment analysis and conversions of gene lists (2019 update) , 2019, Nucleic Acids Res..

[15]  P. Thomas,et al.  Protocol Update for large-scale genome and gene function analysis with the PANTHER classification system (v.14.0) , 2019, Nature Protocols.

[16]  A. Fernie,et al.  Passing the Baton: Substrate Channelling in Respiratory Metabolism , 2018, Research.

[17]  Martin Eisenacher,et al.  The PRIDE database and related tools and resources in 2019: improving support for quantification data , 2018, Nucleic Acids Res..

[18]  M. S. van der Knaap,et al.  Vanishing white matter: a leukodystrophy due to astrocytic dysfunction , 2018, Brain pathology.

[19]  R. Aquilani,et al.  Protein-Amino Acid Metabolism Disarrangements: The Hidden Enemy of Chronic Age-Related Conditions , 2018, Nutrients.

[20]  Maarten H. P. Kole,et al.  Axonal abnormalities in vanishing white matter , 2018, Annals of clinical and translational neurology.

[21]  W. Huber,et al.  Proteome-wide identification of ubiquitin interactions using UbIA-MS , 2018, Nature Protocols.

[22]  O. Elroy-Stein.  Mitochondrial malfunction in vanishing white matter disease: a disease of the cytosolic translation machinery , 2017, Neural regeneration research.

[23]  M. S. van der Knaap,et al.  Leukodystrophies: a proposed classification system based on pathological changes and pathogenetic mechanisms , 2017, Acta Neuropathologica.

[24]  O. Elroy-Stein,et al.  Mutant eIF2B leads to impaired mitochondrial oxidative phosphorylation in vanishing white matter disease , 2017, Journal of neurochemistry.

[25]  Jüergen Cox,et al.  The MaxQuant computational platform for mass spectrometry-based shotgun proteomics , 2016, Nature Protocols.

[26]  Mila Ljujic,et al.  The integrated stress response , 2016, EMBO reports.

[27]  Ruedi Aebersold,et al.  Mass-spectrometric exploration of proteome structure and function , 2016, Nature.

[28]  M. Kamermans,et al.  Astrocytes are central in the pathomechanisms of vanishing white matter. , 2016, The Journal of clinical investigation.

[29]  Seth G. N. Grant,et al.  Identification of Vulnerable Cell Types in Major Brain Disorders Using Single Cell Transcriptomes and Expression Weighted Cell Type Enrichment , 2016, Front. Neurosci..

[30]  C. Proud,et al.  eIF2B: recent structural and functional insights into a key regulator of translation. , 2015, Biochemical Society transactions.

[31]  H. Prange,et al.  „Vanishing white matter disease“ , 2011, Der Nervenarzt.

[32]  S. Goldman,et al.  Defective Glial Maturation in Vanishing White Matter Disease , 2011, Journal of neuropathology and experimental neurology.

[33]  G. Scheper,et al.  Leukoencephalopathy With Vanishing White Matter: A Review , 2010, Journal of neuropathology and experimental neurology.

[34]  Sébastien Lê,et al.  FactoMineR: An R Package for Multivariate Analysis , 2008 .

[35]  F. Carrari,et al.  Respiratory metabolism: glycolysis, the TCA cycle and mitochondrial electron transport. , 2004, Current opinion in plant biology.

[36]  S. Naidu,et al.  Mutations in each of the five subunits of translation initiation factor eIF2B can cause leukoencephalopathy with vanishing white matter , 2002, Annals of neurology.

[37]  Rune R. Frants,et al.  Subunits of the translation initiation factor eIF2B are mutant in leukoencephalopathy with vanishing white matter , 2001, Nature Genetics.

[38]  W. Brück,et al.  Myelinopathia centralis diffusa (vanishing white matter disease): Evidence of apoptotic oligodendrocyte degeneration in early lesion development , 2001, Annals of neurology.

[39]  A. Hart,et al.  Defining and categorizing leukoencephalopathies of unknown origin: MR imaging approach. , 1999, Radiology.

[40]  D. Rodriguez,et al.  Phenotypic variation in leukoencephalopathy with vanishing white matter. , 1999, Neurology.

[41]  J. Valk,et al.  Phenotypic variation in leukoencephalopathy with vanishing white matter , 1998, Neurology.

[42]  G. Brown,et al.  Cellular energy utilization and molecular origin of standard metabolic rate in mammals. , 1997, Physiological reviews.

[43]  P. Scheffer,et al.  Hyaluronan accumulation and arrested oligodendrocyte progenitor maturation in vanishing white matter disease. , 2013, Brain : a journal of neurology.

[44]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..

[45]  C. Proud,et al.  Regulation of eukaryotic initiation factor eIF2B. , 2001, Progress in molecular and subcellular biology.

[46]  Susumu Goto,et al.  KEGG: Kyoto Encyclopedia of Genes and Genomes , 2000, Nucleic Acids Res..